France Biotech dedicated the relevance of the Group by choosing Hervé Balusson, on June 12, as new member of board of directors.
Visionary, Hervé Balusson, CEO of Olmix Group always has been, but he knew by determination turn his vision into an innovative reality.
France Biotech promotes the best French Biotechnology companies in France and abroad. France Biotech dedicated the relevance of the Group by choosing Hervé Balusson, on June 12, as new member of board of directors.
Olmix has been selected to represent the French excellence in term of biotechnology innovation for the « French Life Science Days » launched by France Biotech on June 25 and 26 in New-York.
This new initiative by France Biotech aims at fostering and boosting the connections between French public companies and investors worldwide in an effort to facilitate exchanges and demonstrate the solidity of our own financial community.
For this event, Hervé Balusson was interviewed on June 26 by Grégoire Favet, journalist for BFM Business. He presented in the show “Intégrale Bourse” (BFM Business), the Group innovations in nutrition animal and vegetal.
See the full interview in BFM Business (French): Interview Hervé Balusson, CEO Olmix Group.
English subtitled Interview: